These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 10448826

  • 1. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R, Wagner ML, Sachdeo S, Shumaker RC, Lyness WH, Rosenberg A, Ward D, Perhach JL.
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [Abstract] [Full Text] [Related]

  • 2. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML, Graves NM, Marienau K, Holmes GB, Remmel RP, Leppik IE.
    Epilepsia; 1991 Aug; 32(3):398-406. PubMed ID: 1904346
    [Abstract] [Full Text] [Related]

  • 3. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R, Narang-Sachdeo SK, Shumaker RC, Perhach JL, Lyness WH, Rosenberg A.
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [Abstract] [Full Text] [Related]

  • 4. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM, Holmes GB, Fuerst RH, Leppik IE.
    Epilepsia; 1989 Aug; 30(2):225-9. PubMed ID: 2647472
    [Abstract] [Full Text] [Related]

  • 5. Felbamate increases phenytoin but decreases carbamazepine concentrations.
    Fuerst RH, Graves NM, Leppik IE, Brundage RC, Holmes GB, Remmel RP.
    Epilepsia; 1988 Aug; 29(4):488-91. PubMed ID: 3391153
    [Abstract] [Full Text] [Related]

  • 6. Felbamate.
    Leppik IE.
    Epilepsia; 1995 Aug; 36 Suppl 2():S66-72. PubMed ID: 8784215
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy.
    Sachdeo RC, Narang-Sachdeo S, Montgomery PA, Shumaker RC, Perhach JL, Lyness WH, Rosenberg A.
    J Clin Pharmacol; 1998 Feb; 38(2):184-90. PubMed ID: 9549651
    [Abstract] [Full Text] [Related]

  • 8. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M, Riva R, Albani F, Baruzzi AA.
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [Abstract] [Full Text] [Related]

  • 9. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD, Franklin ME, Glue P, Banfield CR, Radwanski E, McLaughlin DB, McIntyre ME, Dickinson RG, Eadie MJ.
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [Abstract] [Full Text] [Related]

  • 10. Felbamate in experimental model of status epilepticus.
    Mazarati AM, Baldwin RA, Sofia RD, Wasterain CG.
    Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
    [Abstract] [Full Text] [Related]

  • 11. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
    Sachdeo RC, Sachdeo SK, Levy RH, Streeter AJ, Bishop FE, Kunze KL, Mather GG, Roskos LK, Shen DD, Thummel KE, Trager WF, Curtin CR, Doose DR, Gisclon LG, Bialer M.
    Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
    [Abstract] [Full Text] [Related]

  • 12. Blood-brain barrier penetration of felbamate.
    Cornford EM, Young D, Paxton JW, Sofia RD.
    Epilepsia; 1992 Jul; 33(5):944-54. PubMed ID: 1396440
    [Abstract] [Full Text] [Related]

  • 13. Felbamate levels in patients with epilepsy.
    Harden CL, Trifiletti R, Kutt H.
    Epilepsia; 1996 Mar; 37(3):280-3. PubMed ID: 8598188
    [Abstract] [Full Text] [Related]

  • 14. Felbamate: successful development of a new compound for the treatment of epilepsy.
    Schmidt D.
    Epilepsia; 1993 Mar; 34 Suppl 7():S30-3. PubMed ID: 8243376
    [Abstract] [Full Text] [Related]

  • 15. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE.
    Epilepsia; 1994 Mar; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [Abstract] [Full Text] [Related]

  • 16. The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.
    Banfield CR, Zhu GR, Jen JF, Jensen PK, Schumaker RC, Perhach JL, Affrime MB, Glue P.
    Ther Drug Monit; 1996 Feb; 18(1):19-29. PubMed ID: 8848816
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin, and one phenytoin metabolite in human plasma by high-performance liquid chromatography.
    Romanyshyn LA, Wichmann JK, Kucharczyk N, Shumaker RC, Ward D, Sofia RD.
    Ther Drug Monit; 1994 Feb; 16(1):90-9. PubMed ID: 8160262
    [Abstract] [Full Text] [Related]

  • 18. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
    Gordon R, Gels M, Wichmann J, Diamantis W, Sofia RD.
    Epilepsia; 1993 Feb; 34(2):367-71. PubMed ID: 8453946
    [Abstract] [Full Text] [Related]

  • 19. Felbamate-induced headache.
    Ettinger AB, Jandorf L, Berdia A, Andriola MR, Krupp LB, Weisbrot DM.
    Epilepsia; 1996 May; 37(5):503-5. PubMed ID: 8617182
    [Abstract] [Full Text] [Related]

  • 20. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
    Albani F, Theodore WH, Washington P, Devinsky O, Bromfield E, Porter RJ, Nice FJ.
    Epilepsia; 1991 May; 32(1):130-2. PubMed ID: 1985822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.